Cytotoxic Effects of Sorafenib, Lapatinib, and Bevacizumab, Alone and in Combination, on Medullary Thyroid Carcinoma Cells. [PDF]
Altun G, Yönem Ö.
europepmc +1 more source
Choroidal metastases and exudative retinal detachment in medullary thyroid carcinoma. [PDF]
Shukla A +3 more
europepmc +1 more source
The Pitfalls of Calcitonin as a Tumor Marker: Real-Life Data of Patients with Elevated Basal Calcitonin Levels but Without Evidence of Medullary Thyroid Carcinoma. [PDF]
Lederer AK +8 more
europepmc +1 more source
Differentiating medullary thyroid carcinoma from papillary thyroid carcinoma using ultrasound viscosity imaging: a preliminary study. [PDF]
Zhang Q +8 more
europepmc +1 more source
Comment on "Evaluating the necessity of prophylactic lateral neck dissection in medullary thyroid carcinoma based on preoperative calcitonin levels: a multicenter retrospective cohort study". [PDF]
Chen Y, Hong S, Chen Y.
europepmc +1 more source
Systemic therapies for medullary thyroid carcinoma: state of the art. [PDF]
Román-González A +4 more
europepmc +1 more source
A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown Primary. [PDF]
Seguchi K +5 more
europepmc +1 more source
Machine-learning prediction of 3- and 5-year mortality in lymph-node-positive medullary thyroid carcinoma: a study based on the SEER database and external validation in a Chinese cohort. [PDF]
Yang S, Zhao R.
europepmc +1 more source
Detection of SEZ6, a Therapeutic Target, in Medullary Thyroid Carcinoma.
Xu B +12 more
europepmc +1 more source

